Nanoparticles have emerged as a promising alternative to
conventional methods in various fields, including the pharmaceutical industry.
They have been used to preserve drugs with potential therapeutic benefits, find
new uses for old medicines, and deliver biopharmaceuticals. Despite the
advancements in drug delivery systems, conventional methods often face significant
challenges, including poor solubility, limited bioavailability, and systemic
side effects. These limitations hinder the effective delivery of both
hydrophilic and lipophilic therapeutic agents, resulting in suboptimal
treatment outcomes. Lipid-based nanovesicles (L-NVs) have emerged as a
promising solution to these challenges, offering enhanced stability, targeted
delivery, and improved therapeutic efficacy. However, the transition of L-NVs
from laboratory research to commercial application is fraught with regulatory
hurdles, manufacturing complexities, and the need for rigorous safety and
efficacy assessments. This chapter introduces the extensive range of L-NVs
currently available, focusing on the latest generation of non-liposomal L-NVs,
and highlighting their similarities and differences.
Author(s) Details
Shibangi
Mukhopadhyay
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur,
Chhattisgarh, 495009, India.
Nidhi
Agrawal
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur,
Chhattisgarh, 495009, India.
Meenakshi
Jaiswal
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur,
Chhattisgarh, 495009, India.
S.K. Lanjhiyana
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur,
Chhattisgarh, 495009, India.
Alpana
Ram
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur,
Chhattisgarh, 495009, India.
Rashmi
Dewangan
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur,
Chhattisgarh, 495009, India.
Rajkumar
Sironiya
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur,
Chhattisgarh, 495009, India.
Please see the book here:- https://doi.org/10.9734/bpi/prrat/v5/1816
